Trial Profile
A Pilot Study of an Oral Phosphodiesterase Inhibitor (Apremilast) for Atopic Dermatitis in Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2020
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 14 Nov 2014 New trial record